7 and digested with collagenase overnight at 37°C. The next day, tendon digests were strained with 138 a cell strainer to generate single-cell suspensions, which were centrifuged at 800g for 10 minutes 139 to obtain cell pellets. Cells were plated into tissue culture dishes at a high density of 6,666 140 cells/cm 2 to derive parent TSC lines and at a low density of 111 cells/cm 2 to obtain single-cell 141 derived clonal colonies. All cell lines were cultured in growth media comprising high glucose 142 DMEM (Thermo Scientific), 10% Cellect TM Silver fetal bovine serum (MP Biomedicals, Santa 143 Ana, CA) and 1% penicillin-streptomycin solution (Thermo Scientific). Confluent colonies were 144 isolated within 10mm cloning cylinders (0.8 x 0.8 cm, Corning, Inc., Corning, NY) [17] and 145 detached using trypsin-EDTA [18] . Tendon samples from each horse were processed 146 independently to generate three independent parent tendon stem cell lines and thirty clonal 147 tendon stem cell lines (10 per horse). For the experiment, clonal colonies were expanded in 148 culture for two successive passages before plating for differentiation assays and population 149 doublings. A complete cell culture workflow is illustrated in Fig 1.  150 
Cell proliferation 151
Ten thousand cells per cell line were plated in individual wells of 24-welled tissue culture dishes 152 (Nunc™, Thermo Scientific), trypsinized at 70-80% confluence, and counted with an automated 153 cell counter (Beckman Coulter, Brea, CA). Population doubling numbers (DN) and doubling 154 time (DT) for each passage, and cumulative doubling numbers (CDN) over 3 successive 155 passages were calculated using the following formulae: 156 DN = log 2 (cell number at confluence/cell number at seed) 157 DT (days) = culture duration*log(2)/log(cell number at confluence/cell number at seed) 158 Gels for tenogenesis were generated using a previously published method [16] . One million cells 161 were suspended in 5 milliliters of tenogenic growth media comprising high glucose DMEM 162 (Thermo Scientific), 10% Cellect TM Silver fetal bovine serum (MP Biomedicals), 37.5 μ g/ml L-163 ascorbic acid (Sigma-Aldrich, St. Louis, MI), 1% penicillin G (Sigma-Aldrich) and 0.8 mg/ml rat 164 tail collagen I solution (Corning Life Sciences, Tewksbury, MA). Cell/gel suspensions were 165 plated immediately following preparation in individual wells of 4-welled, rectangular dishes 166 (Nunc™, 12.8 x 8.6 cm, Thermo Scientific) affixed with two sterile cloning cylinders (0.8 x 0.8 167 cm, Corning Inc.) set 3 centimeters apart from each other along the longitudinal midline of the 168 well, and held in place by sterile silicone on day 0. Gels were maintained at 37°C, with 5% CO2 169 and 90% humidity. On day 1, growth media was replaced with media containing 50ng/ml BMP-170
Gel histology and analysis of cell alignment 173
Longitudinal sections of each gel were fixed in 4% paraformaldehyde overnight at 4°C, washed 174 in phosphate buffered saline the next day and submitted for histology to a commercial service 175 (Laudier Histology, New York, NY). Two, 6 micron thick longitudinal slices per sample section 176 were stained with Masson's trichrome stain, and images were acquired with a microscope 177 (Olympus Corp, Center Valley, PA) and digital camera (Motic North America, Richmond, BC). 178
Cell alignment was quantified using ImageJ software analytical tools [19] . Fifty cellular angles 179 per histological section and two sections/sample were measured relative to the longitudinal gel 180 axis. Parallel alignment to the longitudinal axis was assigned 0º, and angles of each cell relative 181 to 0º (0º-90º) were averaged for each sample to draw comparisons between samples.
Digital images of each gel were taken on days 1, 3, 5, 7 and 10 to determine the percentage of 184 contracted area at each time point relative to the gel area at day 0. Images were analyzed using 185 ImageJ software analytical tools. 186
Tri-lineage differentiation 187
Tri-lineage differentiation potential was assessed using standard benchtop assays of 188 adipogenesis, osteogenesis and chondrogenesis. For adipogenesis and osteogenesis, cells were 189 plated at high (21,000 cells/cm 2 ) and low densities (4,000 cells/cm 2 ) respectively in tissue culture 190 
Gene expression 207
RNA isolation was performed using the TRIzol TM method (Thermo Scientific). RNA pellets were 208 subjected to RNeasy® spin columns for removal of genomic DNA contamination (QIAGEN 209 Inc., Germantown, MD) and purified RNA was quantified using a NanoDrop TM 2000c 210 spectrophotometer. cDNA was synthesized using a commercial kit (High-Capacity RNA-to-211 cDNA kit, Thermo Scientific). Real-time qPCR (7500 Real-Time PCR System, Thermo 212 Scientific) was performed using custom TaqMan®-MGB probes and primers (Thermo 213 Scientific) included in Table 1 . TaqMan® gene expression assays for equine-specific Runx2 214 (Assay ID: Ec03469741_m1), Sox9 (Assay ID: Ec03469763_s1), Axin2 (Assay ID: APT2CHG) isolated and expanded in culture, twenty-six yielded a million cells or more at confluence, and 241 were seeded in 3D hydrogels for analysis of tenogenic potential. Of these, fifteen clonal TSC 242 lines were additionally seeded for tri-differentiation assays and cultured in growth media to 243 assess population doublings. Thirteen out of fifteen clonal TSC lines expressed Oct-4 in 244 monolayer culture on day 21 (Additional Fig 1) . TSCs successfully adhered to tissue culture-245 treated plastic, formed 3D pellets for chondrogenesis, and expanded to confluence in successive 246 monolayer and 3D cultures. Data from fifteen clonal TSC lines was analyzed for comparisons of 247 differentiation and proliferative potentials, since enough cells could be procured from a single 248 passage of each of these cell lines to enable four differentiation assays and one assay of 249 population doublings. 250 251
Three distinct TSC phenotypes can be found in tendon 252
No unipotent or bipotent clonal TSC lines were obtained in the experiment, as each cell line 253 differentiated toward three or four tissue types. All of the fifteen clonal TSC lines exhibited both 254 chondrogenic and tenogenic potential, evident by the positive upregulation of all markers of the 255 respective lineages upon differentiation. Eight out of fifteen lines differentiated toward adipose, 256 bone, cartilage, and tendon lineages (quadrapotent AOCT phenotype). Five of fifteen were 257 positive for osteogenesis, chondrogenesis and tenogenesis (OCT phenotype) but not 258 adipogenesis, and did not express FABP4 (Ct ≥ 35, no amplification) ( Fig 3A) . The difference in 259 FABP4 expression between AOCT and OCT reached significance (p = 0.0002) and between 260 ACT and OCT approached significance (p = 0.0599). Two of fifteen were positive for 261 adipogenesis, chondrogenesis and tenogenesis (ACT phenotype) but did not undergo 262 osteogenesis, and did not express Runx2 (Ct ≥ 35) ( Fig 3C) . Runx2 expression was significantly 263 decreased in the ACT group and compared to the AOCT (p = 0.0010) and OCT (p = 0.0179) 264 groups. Oil Red O staining confirmed the presence of intracellular oily droplets in adipogenic 265 cultures of the AOCT and ACT groups ( Fig 3B) . Likewise, osteogenic differentiation was 266 confirmed with the formation and staining of calcium nodules and a calcified matrix with 267
Alizarin Red S in cultures of the AOCT and OCT groups ( Fig 3D) . 268 269
Tissue marker gene expression levels and proliferative capacity of TSCs correlates with the 270

ACT, OCT and AOCT phenotypes 271
Gene expression of chondrogenic markers significantly differed among the three phenotypic 272 groups (Fig 4) . Expression of chondrogenic Sox9 was significantly increased in the AOCT group 273 compared to ACT and OCT (p = 0.0167 and 0.0017) on day 21 of chondrogenesis, whereas 274 message levels of aggrecan were the highest in the OCT group, and significantly greater then 275 AOCT (p = 0.029). There were no significant differences in Runx2 expression between the 276 AOCT and OCT groups ( Fig 3C) or in FABP4 expression between the AOCT and ACT groups 277 ( Fig 3A) . 278
The OCT group exhibited significantly greater numbers of cumulative population 279 doublings over three passages compared to the AOCT and ACT groups (p = 0.0105 and 0.0392) 280 ( Fig 5) . Population doubling numbers decreased in passages 4 and 5 relative to passage 3 in all 281 three groups, and this difference reached significance with the AOCT group. 282 283 Quadra-differentiation potent TSCs differentiate to express the optimal composite tendon 284 phenotype Significant differences were noted in tendon gene expression between the AOCT and OCT 286 groups ( Fig 6) . Specifically, scleraxis and mohawk were expressed >3-fold higher in the AOCT 287 group compared to the OCT group (p = 0.0454 for scleraxis and 0.0431 for mohawk). Expression 288 of collagen type III was significantly elevated in the OCT group compared to AOCT (p = 289 0.0315). In contrast, collagen type I expression remained unaffected by TSC differentiation 290 phenotype. No between group differences in tenascin C, Axin2 or FSP1 expressions were 291 observed. 292
All groups contracted collagen matrix in three dimensions albeit to different degrees over 293 10 days (Fig 7) . Significant differences were noted in contracted gel area at two time points 294 between groups ( Fig 7A) . Specifically, the ACT group was significantly less contracted than the 295 AOCT and OCT groups on day 5 (p = 0.0004 and 0.0008) and day 7 (p = 0.0031 and 0.0026). 296
All groups exhibited a uniform distribution of TSCs in three dimensions on day 10 ( Fig  297   8 ). A greater proportion of TSCs (>90%) in all groups were highly aligned to the axis of tension 298 ( Fig 8A) , and exhibited elongated cell morphologies. No significant differences in cell alignment 299 were observed between the three groups ( Fig 8B) . 300
DISCUSSION 302
The goal of this study was to determine whether clonal TSC lines obtained from individual TSCs 303 are diverse in their phenotypic character, and the functional contributions of each phenotype to in 304 vitro differentiation and proliferation. Three distinct TSC phenotypes were identified, and the 305 most significant differences correlated to the presence or lack of adipogenic potential. TSCs of 306 the AOCT phenotype strongly differentiated to a composite tendon-like construct, most 307 remarkably by a significant increase in their expression of scleraxis and mohawk. In contrast, 308
TSCs of the OCT phenotype exhibited significantly increased proliferative capacity compared to 309 the AOCT and ACT groups. 310 This is the first study to investigate the tenogenic potentials of individual TSCs or 311 multipotent clonal TSC lines from any species. In the absence of tendon-specific markers, we 312 evaluated a range of markers that collectively identify the tendon phenotype [11, 21] this study, we did not achieve significant differences in their expression patterns. 324 A recent study revealed the presence of a highly proliferative subpopulation of Axin2 and 325 scleraxis co-expressing TSCs at the site of healing in injured tendons, suggesting this 326 subpopulation of cells may be the first responders to tendon injury in vivo [31] . Our results 327 suggest that TSCs of the highly proliferative, Axin2-expressing OCT phenotype may represent 328 this subpopulation. In contrast, scleraxis expression was significantly greater in the AOCT 329 compared to the OCT group. This result is in support of the hypothesis that Wnt signaling suppresses tenogenic differentiation in TSCs, specifically by downregulating the expression of 331 scleraxis [32] . 332
In response to uniaxial strain along a longitudinal axis, TSCs can contract a disorganized 333 collagenous matrix to an anisotropic, tendon-like structure with parallel-aligned cells and 334 collagen fibers [33] [34] [35] [36] . Our tenogenesis assay successfully and consistently generated tendon-335 like constructs with aligned cells of elongated morphologies on day 10 of culture. The reduced 336 contraction of the ACT group in this study suggests that downregulation of Runx2 expression in 337
TSCs may impede tendon repair in vivo. One study suggests that overexpression of Runx2 may 338 augment tendon-to-bone healing, by inducing site-specific rather than heterotopic bone 339 formation [37] . 340
Expansion of single-cell derived colonies is notoriously difficult in vitro, and limited this 341 study to fifteen clonal TSC lines. Feeder layers, growth factors or alternative methods to 342 supplement cell growth were not used in this study to avoid potential interference with study 343 outcomes. However, sufficient cell numbers were acquired from fifteen TSCs to enable gene 344 expression analysis as a superior outcome of differentiation as opposed to conventional stain 345 absorbance and microscopy. In contrast to a previous study on trilineage differentiation of TSCs 346 [8] , we did not identify clones with solely adipogenic, osteogenic or chondrogenic potential. This 347 may be attributed to species-related differences, or the requirement of highly proliferative clones 348 to simultaneously assess trilineage, tenogenic and proliferative capacities. Oct-4 is a transcription factor. 515 
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